These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 3814492)
1. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. Akerman M; Brandt L; Johnson A; Olsson H Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492 [TBL] [Abstract][Full Text] [Related]
2. Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. del Vecchio MT; Leoncini L; Buerki K; Kraft R; Megha T; Barbini P; Tosi P; Cottier H Int J Cancer; 1991 Jan; 47(1):38-43. PubMed ID: 1985876 [TBL] [Abstract][Full Text] [Related]
3. Mitoses in non-Hodgkin's lymphomas. Frequency and prognostic relevance. Donhuijsen K Pathol Res Pract; 1987 Jun; 182(3):352-7. PubMed ID: 3628094 [TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group. Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008 [TBL] [Abstract][Full Text] [Related]
5. Mitotic activity and survival in advanced non-Hodgkin's lymphoma of unfavourable histology. Brandt L; Johnson A; Olsson H; Akerman M Eur J Cancer; 1990 Mar; 26(3):227-30. PubMed ID: 2141480 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141 [TBL] [Abstract][Full Text] [Related]
7. Histologic subtypes and survival of Chinese patients with non-Hodgkin's lymphomas. Liang R; Loke SL; Ho FC; Chiu E; Chan TK; Todd D Cancer; 1990 Oct; 66(8):1850-5. PubMed ID: 2208041 [TBL] [Abstract][Full Text] [Related]
8. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas. Hiddemann W; Unterhalt M Blood Rev; 1994 Dec; 8(4):225-33. PubMed ID: 7888829 [TBL] [Abstract][Full Text] [Related]
9. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report. Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939 [TBL] [Abstract][Full Text] [Related]
10. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma]. Glińska H; Papla B; Siuda M; Zulichowska J Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182 [TBL] [Abstract][Full Text] [Related]
12. Primary non-Hodgkin's lymphomas of the female breast. Giardini R; Piccolo C; Rilke F Cancer; 1992 Feb; 69(3):725-35. PubMed ID: 1730123 [TBL] [Abstract][Full Text] [Related]
13. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)]. Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031 [TBL] [Abstract][Full Text] [Related]
14. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group. Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680 [TBL] [Abstract][Full Text] [Related]
15. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]. Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418 [TBL] [Abstract][Full Text] [Related]
16. Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registry. D'Amore F; Christensen BE; Thorling K; Pedersen M; Jensen MK; Boesen AM; Andersen E; Johansen P; Mortensen LS Leuk Lymphoma; 1993 Dec; 12(1-2):69-77. PubMed ID: 8161937 [TBL] [Abstract][Full Text] [Related]
17. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Cowan RA; Harris M; Jones M; Crowther D Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100 [TBL] [Abstract][Full Text] [Related]
18. Primary malignant lymphoma of the intestine: clinicopathologic and immunohistochemical studies of 39 cases. Kojima M; Nakamura S; Kurabayashi Y; Shimizu K; Hosomura Y; Ohno Y; Itoh H; Yoshida K; Sano T; Sakurai S Pathol Int; 1995 Feb; 45(2):123-30. PubMed ID: 7742924 [TBL] [Abstract][Full Text] [Related]
19. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma. Joensuu H; Ristamäki R; Söderström KO; Jalkanen S J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487 [TBL] [Abstract][Full Text] [Related]
20. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy]. Hiddemann W Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]